Growing at a relatively modest CAGR of 4.6%, the worldwide market for oxycodone is likely to touch a market revenue of US$ 4 Billion through 2028 end—reflecting absolute dollar prospects of US$ 181.3 Million, during 2018-2019. An increase in the number of patients suffering from fatally-ill ailments, such as HIV and cancer, and a higher …
Continue reading “Government Support and New Drug Development Boosts the Oxycodone Market”